Deutsche Forschungsgemeinschaft, Senatskommission zur Beurteilung der gesundheitlichen Unbedenklichkeit von Lebensmitteln: Stellungnahme zur potentiellen Beteiligung einer oralen Glutamat-Aufnahme an chronischen neurodegenerativen Erkrankungen. vom 8. April 2005. S. 3. (PDF).
Chiaki Sano: History of glutamate production. In: The American Journal of Clinical Nutrition. 90. Jahrgang, Nr.3, September 2009, S.728S-732S, doi:10.3945/ajcn.2009.27462F, PMID 19640955.
Rolls ET: Functional neuroimaging of umami taste: what makes umami pleasant? In: The American Journal of Clinical Nutrition. 90. Jahrgang, Nr.3, September 2009, S.804S-813S, doi:10.3945/ajcn.2009.27462R, PMID 19571217.
Yamaguchi S, Takahashi C: Interactions of monosodium glutamate and sodium chloride on saltiness and palatability of a clear soup. In: Journal of Food Science. 49. Jahrgang, Nr.1, Januar 1984, S.82–85, doi:10.1111/j.1365-2621.1984.tb13675.x.
Freeman, M: Reconsidering the effects of monosodium glutamate: A literature review. In: Journal of the American Academy of Nurse Practicioners. 18. Jahrgang, Nr.10, 2006, S.482–486, doi:10.1111/j.1745-7599.2006.00160.x, PMID 16999713.
Freeman M.: Reconsidering the effects of monosodium glutamate: a literature review. In: J Am Acad Nurse Pract. 18. Jahrgang, Nr.10, Oktober 2006, S.482–6, doi:10.1111/j.1745-7599.2006.00160.x, PMID 16999713.
Willams, A. N., and Woessner, K.M.: Monosodium glutamate 'allergy': menace or myth? In: Clinical & Experimental Allergy. 39. Jahrgang, Nr.5, 2009, S.640–646, doi:10.1111/j.1365-2222.2009.03221.x.
Z Shi, ND Luscombe-Marsh, GA Wittert, B Yuan, Y Dai, X Pan, AW Taylor: Monosodium glutamate is not associated with obesity or a greater prevalence of weight gain over 5 years: Findings from the Jiangsu Nutrition Study of Chinese adults. In: The British journal of nutrition. 104. Jahrgang, Nr.3, 2010, S.457–463, doi:10.1017/S0007114510000760, PMID 20370941.
N. J. Maragakis, J. D. Rothstein: Glutamate transporters in neurologic disease. In: Archives of neurology. Band 58, Nummer 3, März 2001, S. 365–370, doi:10.1001/archneur.58.3.365, PMID 11255439 (Review): “Glutamate is the primary excitatory amino acid neurotransmitter in the human brain. It is important in synaptic plasticity, learning, and development. Its activity at the synaptic cleft is carefully balanced by receptor inactivation and glutamate reuptake. When this balance is upset, excess glutamate can itself become neurotoxic. […] This overactivation leads to an enzymatic cascade of events ultimately resulting in cell death.”
Loliger J: Function and importance of Glutamate for Savory Foods. In: Journal of Nutrition. 130. Jahrgang, 4s Suppl, April 2000, S.915s-920s, PMID 10736352.
Chiaki Sano: History of glutamate production. In: The American Journal of Clinical Nutrition. 90. Jahrgang, Nr.3, September 2009, S.728S-732S, doi:10.3945/ajcn.2009.27462F, PMID 19640955.
Rolls ET: Functional neuroimaging of umami taste: what makes umami pleasant? In: The American Journal of Clinical Nutrition. 90. Jahrgang, Nr.3, September 2009, S.804S-813S, doi:10.3945/ajcn.2009.27462R, PMID 19571217.
Hermanussen M. et al.: Obesity, voracity and short stature: the impact of glutamate on the regulation of appetite. European Journal of Clinical Nutrition. 2006; 60, S. 25–31, PMID 16132059.
Walker R, Lupien JR: The safety evaluation of monosodium glutamate. In: Journal of Nutrition. 130. Jahrgang, 4S Suppl, April 2000, S.1049S-1052S, PMID 10736380.
Freeman, M: Reconsidering the effects of monosodium glutamate: A literature review. In: Journal of the American Academy of Nurse Practicioners. 18. Jahrgang, Nr.10, 2006, S.482–486, doi:10.1111/j.1745-7599.2006.00160.x, PMID 16999713.
Raiten DJ, Talbot JM, Fisher KD: Executive Summary from the Report: Analysis of Adverse Reactions to Monosodium Glutamate (MSG). In: Journal of Nutrition. 126. Jahrgang, Nr.6, 1996, S.1743–1745, PMID 7472671.
R. S. Geha, A. Beiser, C. Ren, R. Patterson, P. A. Greenberger, L. C. Grammer, A. M. Ditto, K. E. Harris, M. A. Shaughnessy, P. R. Yarnold, J. Corren, A. Saxon: Review of alleged reaction to monosodium glutamate and outcome of a multicenter double-blind placebo-controlled study. In: The Journal of nutrition. Band 130, Nummer 4S Suppl, April 2000, S. 1058S–1062S, PMID 10736382 (Review).
Freeman M.: Reconsidering the effects of monosodium glutamate: a literature review. In: J Am Acad Nurse Pract. 18. Jahrgang, Nr.10, Oktober 2006, S.482–6, doi:10.1111/j.1745-7599.2006.00160.x, PMID 16999713.
Z Shi, ND Luscombe-Marsh, GA Wittert, B Yuan, Y Dai, X Pan, AW Taylor: Monosodium glutamate is not associated with obesity or a greater prevalence of weight gain over 5 years: Findings from the Jiangsu Nutrition Study of Chinese adults. In: The British journal of nutrition. 104. Jahrgang, Nr.3, 2010, S.457–463, doi:10.1017/S0007114510000760, PMID 20370941.
Stevenson, D. D.: Monosodium glutamate and asthma. In: J. Nutr. 130. Jahrgang, 4S Suppl, 2000, S.1067S-1073S, PMID 10736384.
N. J. Maragakis, J. D. Rothstein: Glutamate transporters in neurologic disease. In: Archives of neurology. Band 58, Nummer 3, März 2001, S. 365–370, doi:10.1001/archneur.58.3.365, PMID 11255439 (Review): “Glutamate is the primary excitatory amino acid neurotransmitter in the human brain. It is important in synaptic plasticity, learning, and development. Its activity at the synaptic cleft is carefully balanced by receptor inactivation and glutamate reuptake. When this balance is upset, excess glutamate can itself become neurotoxic. […] This overactivation leads to an enzymatic cascade of events ultimately resulting in cell death.”
nytimes.com
Nicholas bakalar: Nutrition: MSG Use Is Linked to Obesity, The New York Times, 25. August 2008. Abgerufen am 10. November 2010 „Consumption of monosodium glutamate, or MSG, the widely used food additive, may increase the likelihood of being overweight, a new study says.“